Literature DB >> 29901108

Blocking the Nav1.5 channel using eicosapentaenoic acid reduces migration and proliferation of ovarian cancer cells.

Junxiu Liu1, Dawei Liu2, Jasmine J Liu3, Chang Zhao4, Shuzhong Yao1, Liang Hong3.   

Abstract

Activity of the voltage-gated Nav1.5 sodium channel has been reported to be involved in cell proliferation, cancer invasion and gene expression. In addition, eicosapentaenoic acid (EPA) has recently been suggested to inhibit ovarian cancer cell growth and suppress tumor metastasis. The present study aimed to explore the association between EPA, the Nav1.5 sodium channel and ovarian cancer cells. Using patch-clamp technique and RNA interference approaches, sodium currents were recorded in epithelial ovarian cancer cells, and it was confirmed that the Nav1.5 channel carried the sodium currents. Furthermore, EPA effectively inhibited sodium currents in a dose-dependent manner, shifted the steady-state inactivation curve of sodium currents to the hyperpolarizing direction and reduced sodium window currents. In addition, EPA induced a shift in the inactivation curve in a dose-dependent manner. Inhibition of the sodium channel, either by EPA or by Nav1.5 knockdown, attenuated ovarian cancer cell migration and proliferation. To the best of our knowledge, the present study is the first to conduct sodium current recording in ovarian cancer cells, and revealed that EPA may inhibit Nav1.5-mediated ovarian cancer cell migration and growth. These findings not only present a potential prognostic biomarker for ovarian cancer, but also provide a strategy towards the development of novel pharmacological treatments for patients with ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29901108     DOI: 10.3892/ijo.2018.4437

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.

Authors:  Gulimirerouzi Fnu; Georg F Weber
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

2.  Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.

Authors:  Mathilde R Rivaud; Mario Delmar; Carol Ann Remme
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 3.  Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment.

Authors:  Concetta Altamura; Maria Raffaella Greco; Maria Rosaria Carratù; Rosa Angela Cardone; Jean-François Desaphy
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

Review 4.  Pharmacological and nutritional targeting of voltage-gated sodium channels in the treatment of cancers.

Authors:  Osbaldo Lopez-Charcas; Piyasuda Pukkanasut; Sadanandan E Velu; William J Brackenbury; Tim G Hales; Pierre Besson; Juan Carlos Gomora; Sébastien Roger
Journal:  iScience       Date:  2021-03-06

5.  Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.

Authors:  Liang Hong; Meihong Zhang; Olivia Thao Ly; Hanna Chen; Arvind Sridhar; Erin Lambers; Brandon Chalazan; Seock-Won Youn; Mark Maienschein-Cline; Leonid Feferman; Sang-Ging Ong; Joseph C Wu; Jalees Rehman; Dawood Darbar
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

6.  Effects of Intravenous Infusion of Lidocaine on Short-Term Outcomes and Survival in Patients Undergoing Surgery for Ovarian Cancer: A Retrospective Propensity Score Matching Study.

Authors:  Hao Zhang; Jiahui Gu; Mengdi Qu; Zhirong Sun; Qihong Huang; Juan P Cata; Wankun Chen; Changhong Miao
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

Review 7.  Fenestropathy of Voltage-Gated Sodium Channels.

Authors:  Tamer M Gamal El-Din; Michael J Lenaeus
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.